Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment

Detalhes bibliográficos
Autor(a) principal: Nunes, Belina
Data de Publicação: 2017
Outros Autores: Pinho, Cristina, Sousa, Cláudia, Melo, Alan Rocha, Bandarra, Narcisa, Silva, Maria Carolina
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970
Resumo: Introduction: The epidemiological and social relevance of dementia and mild cognitive impairment increases with life expectancy and prevalence of metabolic disorders. The recognition of an important role for dietary nutrients on cognitive functioning opens new preventive strategies. This work analyses the association between erythrocyte omega-3 index and omega-6 / omega-3 ratio and cognitive performance/ mild cognitive impairment.Material and Methods: We selected a random sample of individuals registered at a health centre aged ≥ 55 years. Participants were asked about their alimentary habits, erythrocyte indexes were determined and neuropsychological evaluation included the Montreal Cognitive Assessment and a comprehensive test battery.Results: Mean age of 90 participants was 64 years (sd = 5.6), 71.1% had four years of education and 40% of them had more than one vascular risk factor. Limits for omega-3 index and omega-6 / omega-3 ratio were 2.90 - 9.79 (mean = 6.20; sd = 1.50) and 1.14 - 2.95 (mean = 2.12; sd = 0.39), respectively. Montreal Cognitive Assessment scores ranged from 10 to 29 (mean = 22; sd = 4.5), increasing on average 1 - 2 points for above average omega-3 values and an omega-6 / omega-3 ratio ≤ 2 (Group 1) and decreasing 5 - 6 points for omega-3 below mean values and the same omega-6 / omega-3 ratio (Group 2). Prevalence of mild cognitive impairment was 25.6% (95% CI: 16.4 - 34.7), ranging from 12.5% to 83.3% in the two groups above.Discussion: This preliminary study is one of the first analyzing the repercussion of omega-3 index and omega-6 / omega-3 ratio on cognitive functioning, considering additionally the participant clinical and dietary profiles.Conclusion: The association found suggests that omega-3 and omega-6 / omega-3 ratio could be important biomarkers in the prevention of cognitive impairment.
id RCAP_42fb9c2cc0c603496ed1f1d73ec7fc78
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/7970
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive ImpairmentRelevância dos Índices Ómega-3 e Razão Ómega-6 / Ómega-3 na Prevenção do Défice CognitivoAgingCognition DisordersFatty AcidsOmega-3Omega-6Ácidos Gordos Ómega-3Ácidos Gordos Ómega-6EnvelhecimentoPerturbações da CogniçãoIntroduction: The epidemiological and social relevance of dementia and mild cognitive impairment increases with life expectancy and prevalence of metabolic disorders. The recognition of an important role for dietary nutrients on cognitive functioning opens new preventive strategies. This work analyses the association between erythrocyte omega-3 index and omega-6 / omega-3 ratio and cognitive performance/ mild cognitive impairment.Material and Methods: We selected a random sample of individuals registered at a health centre aged ≥ 55 years. Participants were asked about their alimentary habits, erythrocyte indexes were determined and neuropsychological evaluation included the Montreal Cognitive Assessment and a comprehensive test battery.Results: Mean age of 90 participants was 64 years (sd = 5.6), 71.1% had four years of education and 40% of them had more than one vascular risk factor. Limits for omega-3 index and omega-6 / omega-3 ratio were 2.90 - 9.79 (mean = 6.20; sd = 1.50) and 1.14 - 2.95 (mean = 2.12; sd = 0.39), respectively. Montreal Cognitive Assessment scores ranged from 10 to 29 (mean = 22; sd = 4.5), increasing on average 1 - 2 points for above average omega-3 values and an omega-6 / omega-3 ratio ≤ 2 (Group 1) and decreasing 5 - 6 points for omega-3 below mean values and the same omega-6 / omega-3 ratio (Group 2). Prevalence of mild cognitive impairment was 25.6% (95% CI: 16.4 - 34.7), ranging from 12.5% to 83.3% in the two groups above.Discussion: This preliminary study is one of the first analyzing the repercussion of omega-3 index and omega-6 / omega-3 ratio on cognitive functioning, considering additionally the participant clinical and dietary profiles.Conclusion: The association found suggests that omega-3 and omega-6 / omega-3 ratio could be important biomarkers in the prevention of cognitive impairment.Introdução: A relevância epidemiológica e social da demência e do défice cognitivo ligeiro aumenta com a esperança de vida e prevalência das doenças metabólicas. O reconhecimento da importância dos nutrientes no funcionamento cognitivo perspectiva novas estratégias preventivas. Neste trabalho analisamos a associação entre os valores do índice ómega-3 e da razão ómega-6 / ómega-3 e desempenho cognitivo/ défice cognitivo ligeiro.Material e Métodos: Selecionamos uma amostra aleatória de utentes de um centro de saúde com idade ≥ 55 anos, que foram inquiridos sobre hábitos alimentares e sujeitos a avaliação neuropsicológica, incluindo o Montreal Cognitive Assessment, e determinando-se os índices indicados.Resultados: Os 90 participantes tinham em média 64 anos (dp = 5,6), 71,1% quatro anos de escolaridade e 40% mais de um factor de risco vascular. Os limites dos valores de ómega-3 e da razão ómega-6 / ómega-3 foram respectivamente 2,90 - 9,79 (média = 6,20; dp = 1,50) e 1,14 - 2,95 (média = 2,12; dp = 0,39). A pontuação no Montreal Cognitive Assessment variou entre 10 - 29 (média = 22,0; dp = 4,5), aumentando em média 1 - 2 pontos para valores de ómega-3 acima da média e uma razão ómega-6 / ómega-3 ≤ 2 (Grupo 1) e diminuindo 5 - 6 pontos para um valor de ómega-3 abaixo da média e a mesma razão ómega-6 / ómega-3 (Grupo 2). A prevalência de défice cognitivo ligeiro foi 25,6% (IC 95%:16,4 - 34,7%), variando entre 12,5% e 83,3% nos dois grupos mencionados.Discussão: Este estudo preliminar é um dos primeiros a analisar a repercussão do índice ómega-3 e da razão ómega-6 / ómega-3 na função cognitiva, considerando adicionalmente o perfil clínico e consumo alimentar dos participantes.Conclusão: A associação encontrada sugere que o índice ómega-3 e a razão ómega-6 / ómega-3 podem ser biomarcadores importantes na prevenção da deterioração cognitiva.Ordem dos Médicos2017-03-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970oai:ojs.www.actamedicaportuguesa.com:article/7970Acta Médica Portuguesa; Vol. 30 No. 3 (2017): March; 213-223Acta Médica Portuguesa; Vol. 30 N.º 3 (2017): Março; 213-2231646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/4971https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/5138https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/8965Direitos de Autor (c) 2017 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessNunes, BelinaPinho, CristinaSousa, CláudiaMelo, Alan RochaBandarra, NarcisaSilva, Maria Carolina2022-12-20T11:05:22Zoai:ojs.www.actamedicaportuguesa.com:article/7970Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:31.508353Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
Relevância dos Índices Ómega-3 e Razão Ómega-6 / Ómega-3 na Prevenção do Défice Cognitivo
title Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
spellingShingle Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
Nunes, Belina
Aging
Cognition Disorders
Fatty Acids
Omega-3
Omega-6
Ácidos Gordos Ómega-3
Ácidos Gordos Ómega-6
Envelhecimento
Perturbações da Cognição
title_short Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
title_full Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
title_fullStr Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
title_full_unstemmed Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
title_sort Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
author Nunes, Belina
author_facet Nunes, Belina
Pinho, Cristina
Sousa, Cláudia
Melo, Alan Rocha
Bandarra, Narcisa
Silva, Maria Carolina
author_role author
author2 Pinho, Cristina
Sousa, Cláudia
Melo, Alan Rocha
Bandarra, Narcisa
Silva, Maria Carolina
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Nunes, Belina
Pinho, Cristina
Sousa, Cláudia
Melo, Alan Rocha
Bandarra, Narcisa
Silva, Maria Carolina
dc.subject.por.fl_str_mv Aging
Cognition Disorders
Fatty Acids
Omega-3
Omega-6
Ácidos Gordos Ómega-3
Ácidos Gordos Ómega-6
Envelhecimento
Perturbações da Cognição
topic Aging
Cognition Disorders
Fatty Acids
Omega-3
Omega-6
Ácidos Gordos Ómega-3
Ácidos Gordos Ómega-6
Envelhecimento
Perturbações da Cognição
description Introduction: The epidemiological and social relevance of dementia and mild cognitive impairment increases with life expectancy and prevalence of metabolic disorders. The recognition of an important role for dietary nutrients on cognitive functioning opens new preventive strategies. This work analyses the association between erythrocyte omega-3 index and omega-6 / omega-3 ratio and cognitive performance/ mild cognitive impairment.Material and Methods: We selected a random sample of individuals registered at a health centre aged ≥ 55 years. Participants were asked about their alimentary habits, erythrocyte indexes were determined and neuropsychological evaluation included the Montreal Cognitive Assessment and a comprehensive test battery.Results: Mean age of 90 participants was 64 years (sd = 5.6), 71.1% had four years of education and 40% of them had more than one vascular risk factor. Limits for omega-3 index and omega-6 / omega-3 ratio were 2.90 - 9.79 (mean = 6.20; sd = 1.50) and 1.14 - 2.95 (mean = 2.12; sd = 0.39), respectively. Montreal Cognitive Assessment scores ranged from 10 to 29 (mean = 22; sd = 4.5), increasing on average 1 - 2 points for above average omega-3 values and an omega-6 / omega-3 ratio ≤ 2 (Group 1) and decreasing 5 - 6 points for omega-3 below mean values and the same omega-6 / omega-3 ratio (Group 2). Prevalence of mild cognitive impairment was 25.6% (95% CI: 16.4 - 34.7), ranging from 12.5% to 83.3% in the two groups above.Discussion: This preliminary study is one of the first analyzing the repercussion of omega-3 index and omega-6 / omega-3 ratio on cognitive functioning, considering additionally the participant clinical and dietary profiles.Conclusion: The association found suggests that omega-3 and omega-6 / omega-3 ratio could be important biomarkers in the prevention of cognitive impairment.
publishDate 2017
dc.date.none.fl_str_mv 2017-03-31
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970
oai:ojs.www.actamedicaportuguesa.com:article/7970
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/7970
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/4971
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/5138
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/8965
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2017 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2017 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 30 No. 3 (2017): March; 213-223
Acta Médica Portuguesa; Vol. 30 N.º 3 (2017): Março; 213-223
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1817550844125511680